RxDoctor Payments Data

Heather Murray, APRN

Nurse Practitioner · Cantonment, FLNPI 1538893250

Payments from drug & device makers

$1,250in general payments, 2019–2025

Across 60 payments — averaging $20.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$188
  • Sumitomo Pharma America, Inc.$123
  • Astellas Pharma US Inc$96
  • Sun Pharmaceutical Industries Inc.$95
  • AbbVie$92
  • GSK$68
  • plus $588 from 18 others

What the payments were for

  • Food & beverage$1,15592%
  • Education$958%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,250 in reported general payments places this provider in the 75th percentile of 8,290 nurse practitioner providers in Florida.

See all nurse practitioner providers in Florida

Medicare billing

Part B allowed, 2024
$40,272
Medicare patients
164
Services billed
632

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide43$60,086
OzempicSemaglutide34$30,838
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$15,591
TrulicityDulaglutide17$15,454
JardianceEmpagliflozin11$10,809
EliquisApixaban13$7,469
Breo ElliptaFluticasone/Vilanterol14$6,084
FarxigaDapagliflozin Propanediol13$4,105
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$3,485
Albuterol Sulfate HfaAlbuterol Sulfate72$2,457
Atorvastatin Calcium161$1,630
Valsartan25$1,577
Duloxetine Hcl28$1,255
Tolterodine Tartrate ErTolterodine Tartrate14$1,227
Candesartan Cilexetil15$1,137

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$48$75,54060 claims
Novo NordiskOzempic$188$30,83834 claims
GSKTrelegy Ellipta, Breo Ellipta$68$21,67530 claims
Boehringer IngelheimJardiance$64$10,80911 claims
PfizerEliquis$18$7,46913 claims
AstraZenecaFarxiga$56$4,10513 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 8,290 nurse practitioner providers in Florida.

Other nurse practitioner in Cantonment

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →